Business

Here’s how much people are willing to spend on weight loss drugs, according to a new survey

Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it’s strongly correlated to their annual income.

Previous post Amgen wants in on the booming weight loss drug market — and it’s taking a different approach
Next post What investors should know about the U.S. easing vehicle emissions rules

More Stories